Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Drug Substance Synthesis and Manufacturing services provided by Quotient Sciences

Quotient Sciences
Drug Substance Synthesis and Manufacturing

PDF Upload Mar, 2025

Nazim Kanji Shares Taste Masking Insights in PharmTech Article

07 Feb 2025

// PRESS RELEASE

Quotient's completes $1.4 M project to Improve HPAPI

21 Mar 2025

// PRESS RELEASE

Quotient Recognized as a Winner of 2025 CDMO Leadership Award

27 Feb 2025

// PRESS RELEASE

Nazim Kanji Shares Taste Masking Insights in PharmTech Article

07 Feb 2025

// PRESS RELEASE

Quotient's completes $1.4 M project to Improve HPAPI

21 Mar 2025

// PRESS RELEASE

1
2
3

DATA COMPILATION
#PharmaFlow

Quotient rm 250x250

Contact Supplier

CPhI North America

Booth #1220

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

https://www.youtube.com/embed/RPKM51cDDyM

Xls

CATEGORY PAGE

Quotient Sciences

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Corporate Presentation, Inhaled Product Development, Aseptic Development and Manufacturing, Global Formulation Development & Manufacturing Capabilities, Pre-formulation and Material Sciences, Drug Substance Synthesis and Manufacturing, Modified-Release Formulation Strategies, First Subjects Dosing with VS-041 a Novel Heart Failure Treatment, 14C Human ADME Program for HTD1801, Oxilio & Quotient Announce Regulatory Approval for OXL001, Expansion of Facilities for Translational Pharmaceutics® Programs, Ensysce Biosciences & Quotient Announce a Partnership, Human ADME Studies, Bioanalytical Services, Translational Pharmaceutics®, Formulation Strategies for Poorly Soluble Molecules, Global Formulation Development & Manufacturing Capabilities, Commercial Manufacturing, Clinical Trial Manufacturing, Global Clinical Trial Supplies, GMP Certificate 2019, Financial Impact of Translational Pharmaceutics®, High Potency Handling, Project Management at Quotient Sciences, Pediatrics Services

Corporate Presentation
Inhaled Product Development
Aseptic Development and Manufacturing
Global Formulation Development & Manufacturing Capabilities
Pre-formulation and Material Sciences
Drug Substance Synthesis and Manufacturing
Modified-Release Formulation Strategies
First Subjects Dosing with VS-041 a Novel Heart Failure Treatment
14C Human ADME Program for HTD1801
Oxilio & Quotient Announce Regulatory Approval for OXL001
Expansion of Facilities for Translational Pharmaceutics® Programs
Ensysce Biosciences & Quotient Announce a Partnership
Human ADME Studies
Bioanalytical Services
Translational Pharmaceutics®
Formulation Strategies for Poorly Soluble Molecules
Global Formulation Development & Manufacturing Capabilities
Commercial Manufacturing
Clinical Trial Manufacturing
Global Clinical Trial Supplies
GMP Certificate 2019
Financial Impact of Translational Pharmaceutics®
High Potency Handling
Project Management at Quotient Sciences
Pediatrics Services

VIDEO(s)

Corporate Video, Bioanalysis, Clinical Pharmacology, Clinical Trial Manufacturing, Commercial Manufacturing, Data Sciences, Drug Development Consulting, Drug Substance, Formulation Development, Translational Pharmaceutics®, Bioanalytical Services, Candidate Molecule Selection, CDMO Solutions for Orphan & Rare Diseases, Early Development, Late Development, Orphan Drug Programs, What is Bioanalysis? (BioA), Our Manifesto, Miami Clinical Pharmacology Facility

Corporate Video
Bioanalysis
Clinical Pharmacology
Clinical Trial Manufacturing
Commercial Manufacturing
Data Sciences
Drug Development Consulting
Drug Substance
Formulation Development
Translational Pharmaceutics®
Bioanalytical Services
Candidate Molecule Selection
CDMO Solutions for Orphan & Rare Diseases
Early Development
Late Development
Orphan Drug Programs
What is Bioanalysis? (BioA)
Our Manifesto
Miami Clinical Pharmacology Facility

DIGITAL CONTENT

5 Interview #SpeakPharma, 44 Corporate Content #SupplierSpotlight, 2 Data Compilation #PharmaFlow, 151 News #PharmaBuzz

5 Interview #SpeakPharma
44 Corporate Content #SupplierSpotlight
2 Data Compilation #PharmaFlow
151 News #PharmaBuzz

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

SERVICES

Analytical, Clinical Trials, API Manufacturing, Drug Product Manufacturing, API & Drug Product Development, Packaging

Analytical
- 1 BioAnalytical Services
- 1 Analytical Method Development
Clinical Trials
API Manufacturing
Drug Product Manufacturing
API & Drug Product Development
Packaging
- 5 Clinical Services

KEY SERVICES

Pharmacy Compounding Services, Pharmacy Compounding & Formulation, Formulation Development of Capsules, Development of Nasal Dosage Forms, CDMO for Suspensions, Pediatric Formulation Development

Pharmacy Compounding Services
Pharmacy Compounding & Formulation
Formulation Development of Capsules
Development of Nasal Dosage Forms
CDMO for Suspensions
Pediatric Formulation Development

INSPECTIONS & REGISTRATIONS

11 FDA, 7 EDQM, 1 GDUFA

11 FDA
7 EDQM
1 GDUFA

Active Filter(s):

PI72998

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!